Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation

NCT01810588 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

270

Enrollment

OTHER

Sponsor class

Conditions

Hematologic Malignancies

Interventions

DEVICE: CliniMACS® CD34 Reagent System
DRUG: Fludarabine
DRUG: Melphalan
DRUG: anti-thymocyte globulin (rabbit)
DRUG: Rituximab
RADIATION: Total Body Irradiation
DRUG: Mycophenolate Mofetil
DRUG: Tacrolimus

Sponsor

Weill Medical College of Cornell University